Literature DB >> 22213235

Drug interaction between lenalidomide and itraconazole.

Naoto Takahashi, Masatomo Miura, Yoshihiro Kameoka, Maiko Abumiya, Kenichi Sawada.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22213235     DOI: 10.1002/ajh.22260

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  5 in total

Review 1.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

2.  Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1.

Authors:  Teresa S Hawley; Irene Riz; Wenjing Yang; Yoshiyuki Wakabayashi; Louis Depalma; Young-Tae Chang; Weiqun Peng; Jun Zhu; Robert G Hawley
Journal:  Am J Hematol       Date:  2013-03-08       Impact factor: 10.047

3.  Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial.

Authors:  Ingrid Jakobsen Falk; Johan Lund; Henrik Gréen; Astrid Gruber; Evren Alici; Birgitta Lauri; Cecilie Blimark; Ulf-Henrik Mellqvist; Agneta Swedin; Karin Forsberg; Conny Carlsson; Mats Hardling; Lucia Ahlberg; Kourosh Lotfi; Hareth Nahi
Journal:  Cancer Chemother Pharmacol       Date:  2017-11-25       Impact factor: 3.333

Review 4.  Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide.

Authors:  Nianhang Chen; Simon Zhou; Maria Palmisano
Journal:  Clin Pharmacokinet       Date:  2017-02       Impact factor: 6.447

5.  No clinically significant drug interactions between lenalidomide and P‑glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers.

Authors:  Nianhang Chen; Daniel Weiss; Josephine Reyes; Liangang Liu; Claudia Kasserra; Xiaomin Wang; Simon Zhou; Gondi Kumar; Lilia Weiss; Maria Palmisano
Journal:  Cancer Chemother Pharmacol       Date:  2014-05       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.